SCHEMBL22182071

SCHEMBL22182071

NSCCNc1ccc(-c2ccc(NCCCN3C(=O)c4cccc5cccc(c45)C3=O)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIRT1 Q96EB6 3/20 0.54
▸ HEXA P06865 6/20 0.52
▸ HEXB P07686 6/20 0.52
▸ OGA O60502 1/20 0.50
▸ KDM4E B2RXH2 4/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ POLB P06746 3/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ NR1I2 O75469 1/20 0.46
▸ AHR P35869 1/20 0.46
▸ RAD52 P43351 1/20 0.46
▸ RCE1 Q9Y256 1/20 0.46
▸ ALDH1A1 P00352 4/20 0.46
▸ HPGD P15428 3/20 0.46
▸ MAPT P10636 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ HDAC3 O15379 1/20 0.45
▸ LTA4H P09960 1/20 0.45
▸ HDAC4 P56524 1/20 0.45
▸ HDAC1 Q13547 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22181859 0.87 HEXA (0.63) SIRT1HEXAHEXBOGAKDM4E
SCHEMBL22181902 0.87 SIRT1 (0.57) SIRT1HEXAHEXBOGAKDM4E
SCHEMBL22181854 0.87 SIRT1 (0.57) SIRT1HEXAHEXBOGAKDM4E
SCHEMBL22181861 0.85 SIRT1 (0.53) SIRT1HEXAHEXBOGAKDM4E
SCHEMBL22181870 0.85 SIRT1 (0.57) SIRT1HEXAHEXBOGAKDM4E
SCHEMBL22181917 0.85 SIRT1 (0.57) SIRT1HEXAHEXBOGAKDM4E
SCHEMBL22182098 0.85 SIRT1 (0.57) SIRT1HEXAHEXBOGAKDM4E
SCHEMBL22182093 0.84 SIRT1 (0.54) SIRT1HEXAHEXBOGAKDM4E
SCHEMBL22181857 0.84 SIRT1 (0.56) SIRT1HEXAHEXBOGAKDM4E
SCHEMBL22181911 0.83 SIRT1 (0.58) SIRT1HEXAHEXBOGAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020139291-A1 NAPHTHALIMIDE DERIVATIVES AS ANTI-PARASITIC AGENTS FOR THE TREATMENT OF LEISHMANIASIS AS WELL AS VIRAL, BACTERIAL AND NEOPLASTIC DISEASES ISTANBUL MEDIPOL UNIVERSITESI (TR) 2020-07-02 — — WO disclosed
Send feedback